Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says By: CNBC.com News July 30, 2024 at 07:00 AM EDT Liraglutide is sold under the brand names Saxenda and Victoza, and sales are declining as blockbuster GLP-1s Ozempic and Wegovy skyrocket in demand. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says By: CNBC.com News July 30, 2024 at 07:00 AM EDT Liraglutide is sold under the brand names Saxenda and Victoza, and sales are declining as blockbuster GLP-1s Ozempic and Wegovy skyrocket in demand. Read More >>
